Vaccine effectiveness
COVID-19, Covid-19 vaccines, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses
Dispelling the Myth of “A Pandemic of the Unvaccinated”
Reference: Canadian COVID Care Alliance. (2021). Dispelling the myth of “a pandemic of the unvaccinated.” Retrieved from https://canadiancovidcarealliance.org Summary: The Canadian COVID Care Alliance, comprising over 500 independent healthcare professionals, challenges the narrative that the COVID-19 pandemic is predominantly a crisis among the unvaccinated. The article argues that vaccination rates were high, yet COVID-19 cases
COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses
Critical Review of COVID-19 Vaccines in Australia
Reference: Turni, C., & Lefringhausen, A. (2022). COVID-19 vaccines – An Australian review. Journal of Clinical & Experimental Immunology, 7(3), 491-508. Summary: This review evaluates COVID-19 mRNA vaccines from an Australian perspective, focusing on their safety and efficacy. The authors discuss initial promises versus actual outcomes, citing serious side effects—including deaths—from collected case reports. They
COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses
Comirnaty Vaccine Information
Reference: Pfizer. (2021). Comirnaty 30 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) tozinameran: Package leaflet. Retrieved from [insert URL here] Summary: Comirnaty is a COVID-19 mRNA vaccine designed to prevent illness caused by the SARS-CoV-2 virus, approved for adults and adolescents aged 12 and over. It functions by stimulating the immune
COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses
COVID-19 Infections Among Vaccinated Individuals: A Rising Concern
Reference: King’s College London. (2021). COVID-19 infections among vaccinated individuals: A rising concern. ZOE COVID Study. Summary: A study from King’s College London revealed that as of July 15, 2021, daily symptomatic COVID-19 cases among vaccinated individuals in the UK averaged 15,537, marking a 40% increase from the previous week. Concurrently, unvaccinated cases decreased by
Monkeypox, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses
Ethical and Scientific Considerations for Mpox Vaccination Programs in Africa
Reference: Edeling, H. (2024). Ethical and scientific considerations for Mpox vaccination programs in Africa. SAVIMS. Summary: The article by Dr. Herman Edeling discusses critical ethical and scientific considerations surrounding Mpox vaccination programmes in Africa. It highlights the need for comprehensive clinical assessments and accurate differential diagnoses for blistering skin disorders, emphasising the limitations of current
Monkeypox, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses
Concerns Over Emergency Monkeypox Vaccine Rollout in Africa
Reference: SA Vaccine Injury Medco-Legal Study Group – SAVIMS. (2024, August 18). Statement on proposed emergency roll-out of vaccine program in Africa for monkeypox. Johannesburg, South Africa. Retrieved from www.savims.org.za Summary: The SA Vaccine Injury Medco-Legal Study Group (SAVIMS) has expressed significant concerns regarding the proposed emergency rollout of monkeypox vaccines in Africa, as announced